Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Doctor analysing patient brain scan results

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.

Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.

The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.

Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.

“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

To read more on this topic click here.

Acupuncture may alleviate Parkinson’s symptoms

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Racing around Iceland for Parkinson’s: it’s snow joke

Campaigner John MacPhee shares his highlights from a gruelling 57-hour bike

The Empire State Building lights up for World Parkinson’s Day

A snapshot of World Parkinson’s Day around the world

World Parkinson Congress 2019: the travels of ‘Twitchy Woman’

Sharon Krischer shares her diary from the World Parkinson Congress 2019

Can Covid-19 increase the risk of developing Parkinson’s?

Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion. As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s. Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after. Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in…

New Parkinson’s trial platform could “dramatically speed up the search for a cure”

Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure. This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system. Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions. Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”. She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”

Can higher levels of caffeine and uric acid prevent Parkinson’s?

Higher levels of caffeine and uric acid (a natural waste product) may reduce the risk of Parkinson’s, a new study by researchers in the US has found. As part of the study – published in ‘Journal of Parkinson’s Disease’ – researchers investigated the urate levels and caffeine intake of 566 participants in the Harvard Biomarkers Study, 369 of which had Parkinson’s. The results showed that caffeine intake and uric acid levels were lower in people with Parkinson’s compared to the healthy controls. While the study provides evidence of the link between Parkinson’s and higher uric acid and caffeine levels, the researchers caution that attempts to raise these levels cannot be recommended. Dr Rachit Bakshi, lead investigator of the study, said: “Identifying factors that are linked to lower likelihood of PD, such as caffeine consumption, offer a unique opportunity to understand the disease, and if the link were causal, then possibly…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Racing around Iceland for Parkinson’s: it’s snow joke

Global update

The Empire State Building lights up for World Parkinson’s Day

Global update

World Parkinson Congress 2019: the travels of ‘Twitchy Woman’

Can Covid-19 increase the risk of developing Parkinson’s?

New Parkinson’s trial platform could “dramatically speed up the search for a cure”

Can higher levels of caffeine and uric acid prevent Parkinson’s?

{title}

Subscribe

Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Racing around Iceland for Parkinson’s: it’s snow joke

Global update

The Empire State Building lights up for World Parkinson’s Day

Global update

World Parkinson Congress 2019: the travels of ‘Twitchy Woman’

Can Covid-19 increase the risk of developing Parkinson’s?

New Parkinson’s trial platform could “dramatically speed up the search for a cure”

Can higher levels of caffeine and uric acid prevent Parkinson’s?

{title}

Subscribe

Sign in